Lenz Therapeutics, Inc. (LENZ) — SC 13D/A Filings
All SC 13D/A filings from Lenz Therapeutics, Inc.. Browse 2 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (2)
-
Versant Venture Capital VI Files 13D/A for Lenz Therapeutics
— Nov 8, 2024 Risk: medium
Versant Venture Capital VI, L.P. and its affiliates have filed an amendment to their Schedule 13D, reporting a change in beneficial ownership of Lenz Therapeuti -
Versant Venture Capital VI Files 13D Amendment for LENZ Therapeutics
— Mar 25, 2024 Risk: medium
Versant Venture Capital VI, L.P. and its affiliates have filed an amendment to their Schedule 13D, indicating a change in their beneficial ownership of LENZ The
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX